Inventor · disambiguated record
Mathai Mammen
Also filed as: MAMMEN MATHAI
104 granted patents·14 pending applications·2,388 citations·filing 2000–2022
99Inventor score
Files withTHERAVANCE INC75MAMMEN MATHAI17THERAVANCE BIOPHARMA R&D IP LLC6MU YONGQI5CHRISTENSEN BURTON G4
Top patents by PatentIndex Score
118 records- 0199US7288657B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Oct 30, 2007·71 cites·18 claims
- 0299US6693202B1Muscarinic receptor antagonistsTHERAVANCE INC·Filed 2000·Granted Feb 17, 2004·253 cites·11 claims
- 0398US11247969B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Feb 15, 2022·6 cites·10 claims
- 0498US6635764B2Therapeutic ureasTHERAVANCE INC·Filed 2000·Granted Oct 21, 2003·149 cites·13 claims
- 0597US9045443B2Nitric oxide donor neprilysin inhibitorsMAMMEN MATHAI·Filed 2013·Granted Jun 2, 2015·53 cites·22 claims
- 0697US8053448B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2011·Granted Nov 8, 2011·24 cites·2 claims
- 0797US8034946B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2010·Granted Oct 11, 2011·28 cites·2 claims
- 0897US7910608B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Mar 22, 2011·32 cites·4 claims
- 0997US7659403B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Feb 9, 2010·25 cites·15 claims
- 1097US7585879B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Sep 8, 2009·35 cites·12 claims
- 1197US7550595B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Jun 23, 2009·37 cites·22 claims
- 1297US7524965B2Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activityTHERAVANCE INC·Filed 2007·Granted Apr 28, 2009·44 cites·10 claims
- 1397US7521041B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Apr 21, 2009·27 cites·22 claims
- 1497US7491736B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Feb 17, 2009·29 cites·24 claims
- 1597US7265133B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Sep 4, 2007·65 cites·20 claims
- 1697US7262205B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Aug 28, 2007·50 cites·21 claims
- 1796US10570092B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 25, 2020·8 cites·5 claims
- 1896US10343995B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jul 9, 2019·9 cites·23 claims
- 1996US9452161B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2016·Granted Sep 27, 2016·11 cites·9 claims
- 2096US7803812B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2009·Granted Sep 28, 2010·19 cites·30 claims
- 2196US7560469B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Jul 14, 2009·37 cites·13 claims
- 2296US7524962B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Apr 28, 2009·37 cites·10 claims
- 2396US7524959B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 28, 2009·36 cites·19 claims
- 2496US7521561B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 21, 2009·36 cites·19 claims
- 2596US7514558B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 7, 2009·32 cites·18 claims
- 2696US7479562B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Jan 20, 2009·39 cites·24 claims
- 2796US7456199B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Nov 25, 2008·49 cites·12 claims
- 2896US7355046B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 8, 2008·42 cites·17 claims
- 2996US7345175B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Mar 18, 2008·49 cites·17 claims
- 3096US7141671B2Biphenyl derivativesTHERAVANCE INC·Filed 2004·Granted Nov 28, 2006·145 cites·42 claims
- 3196US6656694B2Method for identifying a ligand for a biological substrateTHERAVANCE INC·Filed 2001·Granted Dec 2, 2003·88 cites·13 claims
- 3295US10106503B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Oct 23, 2018·9 cites·25 claims
- 3395US9926272B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Mar 27, 2018·9 cites·7 claims
- 3495US9283183B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2014·Granted Mar 15, 2016·12 cites·17 claims
- 3595US8912334B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2013·Granted Dec 16, 2014·13 cites·6 claims
- 3695US8557997B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2012·Granted Oct 15, 2013·13 cites·6 claims
- 3795US8273894B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2012·Granted Sep 25, 2012·15 cites·14 claims
- 3895US8173815B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2011·Granted May 8, 2012·15 cites·10 claims
- 3995US8017783B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Sep 13, 2011·17 cites·13 claims
- 4095US7642355B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Jan 5, 2010·32 cites·15 claims
- 4195US7629336B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Dec 8, 2009·29 cites·12 claims
- 4295US7569588B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Aug 4, 2009·34 cites·17 claims
- 4395US7507751B2Biphenyl derivativesTHERAVANCE INC·Filed 2007·Granted Mar 24, 2009·33 cites·21 claims
- 4495US7501442B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Mar 10, 2009·40 cites·23 claims
- 4595US7345060B2Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activityTHERAVANCE INC·Filed 2004·Granted Mar 18, 2008·63 cites·22 claims
- 4694US7879879B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Feb 1, 2011·19 cites·7 claims
- 4794US7687519B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Mar 30, 2010·25 cites·21 claims
- 4894US7687521B2Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activityTHERAVANCE INC·Filed 2009·Granted Mar 30, 2010·23 cites·11 claims
- 4994US7683173B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2008·Granted Mar 23, 2010·23 cites·21 claims
- 5094US7632847B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Dec 15, 2009·24 cites·16 claims
Showing the top 50 of 118 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →